Literature DB >> 21450975

Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice.

Karen L Wozniak1, Mattie L Young, Floyd L Wormley.   

Abstract

Individuals with defects in T cell-mediated immunity (CMI) are highly susceptible to infection with Cryptococcus neoformans. The purpose of these studies was to determine if protection against experimental pulmonary cryptococcosis can be generated in T cell-deficient hosts. BALB/c mice were depleted of CD4⁺and/or CD8⁺ T cells or given an isotype control antibody prior to vaccination with a C. neoformans strain, designated H99γ, previously shown to induce protection against C. neoformans infection in immunocompetent mice. Mice depleted of CD4⁺ or CD8⁺ T cells, but not both subsets, survived an acute pulmonary infection with C. neoformans strain H99γ and a subsequent second challenge with wild-type C. neoformans strain H99. We observed a significant increase in the percentage of CD4⁺ and CD8⁺ T cells expressing the activation marker CD69 in the lungs of mice immunized with C. neoformans strain H99γ prior to a secondary challenge with wild-type cryptococci. CD4⁺ T cells within the lungs of immunized mice also appeared to acquire a predominantly activated effector memory cell phenotype (CD69CD44CCR7⁻ CD45RB⁻ CD62L⁻) following a second pulmonary challenge with wild-type C. neoformans, compared to CD4⁺ T cells from naïve mice. Lastly, immunization of immunocompetent mice with C. neoformans strain H99γ prior to depletion of CD4⁺ and/or CD8⁺ T cells resulted in significant protection against a second challenge with wild-type C. neoformans. Our studies demonstrate that protective immunity against pulmonary cryptococcosis can be generated in immunosuppressed hosts, thus supporting the development of cryptococcal vaccines.

Entities:  

Mesh:

Year:  2011        PMID: 21450975      PMCID: PMC3122518          DOI: 10.1128/CVI.00036-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  40 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts.

Authors:  Marcel Wüthrich; Hanna I Filutowicz; Tom Warner; Bruce S Klein
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Authors:  M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  The wide spectrum of cryptococcal infections.

Authors:  J L Lewis; S Rabinovich
Journal:  Am J Med       Date:  1972-09       Impact factor: 4.965

Review 5.  Innate or adaptive immunity? The example of natural killer cells.

Authors:  Eric Vivier; David H Raulet; Alessandro Moretta; Michael A Caligiuri; Laurence Zitvogel; Lewis L Lanier; Wayne M Yokoyama; Sophie Ugolini
Journal:  Science       Date:  2011-01-07       Impact factor: 47.728

6.  Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.

Authors:  Asda Vibhagool; Somnuek Sungkanuparph; Piroon Mootsikapun; Ploenchan Chetchotisakd; Somsit Tansuphaswaswadikul; Chureeratana Bowonwatanuwong; Atiporn Ingsathit
Journal:  Clin Infect Dis       Date:  2003-05-02       Impact factor: 9.079

Review 7.  Central memory and effector memory T cell subsets: function, generation, and maintenance.

Authors:  Federica Sallusto; Jens Geginat; Antonio Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

8.  Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function.

Authors:  Eulogia Román; Ellen Miller; Allen Harmsen; James Wiley; Ulrich H Von Andrian; Gail Huston; Susan L Swain
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

10.  Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts.

Authors:  Marcel Wuthrich; Hanna I Filutowicz; Tom Warner; George S Deepe; Bruce S Klein
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  35 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.

Authors:  Ashok K Chaturvedi; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  Proteomics       Date:  2013-12       Impact factor: 3.984

Review 3.  Fungal vaccines and immunotherapeutics.

Authors:  Evelyn Santos; Stuart M Levitz
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 4.  Universal fungal vaccines: could there be light at the end of the tunnel?

Authors:  Mawieh Hamad
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

5.  Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species.

Authors:  Camaron R Hole; Chrissy M Leopold Wager; Andrew S Mendiola; Karen L Wozniak; Althea Campuzano; Xin Lin; Floyd L Wormley
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 6.  The intracellular life of Cryptococcus neoformans.

Authors:  Carolina Coelho; Anamelia L Bocca; Arturo Casadevall
Journal:  Annu Rev Pathol       Date:  2013-09-16       Impact factor: 23.472

Review 7.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

Review 8.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

Review 9.  Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

10.  STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Floyd L Wormley
Journal:  J Immunol       Date:  2014-09-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.